My Cart
$0.00
0

Ensuring timely antibody delivery in the face of supply chain challenges - contact us for solutions

  • Home
  • Goat F(ab')2 Anti-Mouse Ig, Human ads-UNLB

Goat F(ab')2 Anti-Mouse Ig, Human ads-UNLB

Cat. No.:
1012-01
Purified Goat F(ab')2 Anti-Mouse Ig antibody with minimal reactivity to human proteins for use in ELISA, flow cytometry, immunocytochemistry, western blot, ELISpot, and stimulation assays.
$83.00
Size Price (USD) Quantity
0.5 mg $83.00
Technical Bulletin Safety Datasheet

Product Specifications

More Information
Isotype Goat F(ab')2 IgG
Isotype Control Goat F(ab')2 IgG-UNLB
Specificity Reacts with the heavy and light chains of mouse IgG1, IgG2a, IgG2b, IgG2c, IgG3, IgM, and IgA
Source Pepsin digest of Goat Anti-Mouse Ig, Human ads (SB Cat. No. 1010)
Cross Adsorption Human immunoglobulins and pooled sera; may react with immunoglobulins from other species
Conjugate UNLB (Unconjugated)
Buffer Formulation Borate buffered saline, pH 8.2
Clonality Polyclonal
Concentration 0.5 mg/mL
Volume 1.0 mL
Recommended Storage 2-8°C
Applications Quality tested applications for relevant formats include -
ELISA 1-6
FLISA
Flow Cytometry 8-21

Other referenced applications for relevant formats include -
ELISpot 5,7
Immunocytochemistry 22,23
Western Blot 24
Stimulation 25-27
RRID Number AB_2794158

Documentation

Documentation
Technical Bulletin Safety Datasheet
Certificate of Analysis Lookup

Enter the Catalog Number and Lot Number for the Certificate of Analysis you wish to view


Need help with this product?
Email technical support
or call 800.722.2255

Other Conjugates and Formulations

Citations

  1. 1. Gerth AJ, Lin L, Peng SL. T-bet regulates T-independent IgG2a class switching. Int Immunol. 2003;15:937-44. (ELISA)
  2. 2. Oble DA, Collett E, Hsieh M, Ambjørn M, Law J, Dutz J, et al. A novel T cell receptor transgenic animal model of seborrheic dermatitis-like skin disease. J Invest Dermatol. 2005;124:151-9. (ELISA)
  3. 3. Kang T, Oh G, Scandella E, Bolinger B, Ludewig B, Kovalenko A, et al. Mutation of a self-processing site in caspase-8 compromises its apoptotic but not its nonapoptotic functions in bacterial artificial chromosome-transgenic mice. J Immunol. 2008;181:2522-32. (ELISA)
  4. 4. Seo KY, Han SJ, Cha H, Seo S, Song J, Chung S, et al. Eye mucosa: an efficient vaccine delivery route for inducing protective immunity. J Immunol. 2010;185:3610-9. (ELISA)
  5. 5. Chang J, Cha H, Chang S, Ko H, Seo S, Kweon M. IFN-γ secreted by CD103+ dendritic cells leads to IgG generation in the mesenteric lymph node in the absence of vitamin A. J Immunol. 2011;186:6999-7005. (ELISA, ELISPOT)
  6. 6. Sun Y, Peng I, Senger K, Hamidzadeh K, Reichelt M, Baca M, et al. Critical role of activation induced cytidine deaminase in experimental autoimmune encephalomyelitis. Autoimmunity. 2013;46:157-67. (ELISA)
  7. 7. Cha H, Ko H, Kim E, Chang S, Seo S, Cuburu N, et al. Mucosa-associated epithelial chemokine/CCL28 expression in the uterus attracts CCR10+ IgA plasma cells following mucosal vaccination via estrogen control. J Immunol. 2011;187:3044-52. (ELISPOT)
  8. 8. Coccia MA, Brams P. High titer, prostate specific antigen-specific human IgG production by hu-PBL-SCID mice immunized with antigen-mouse IgG2a complex-pulsed autologous dendritic cells. J Immunol. 1998;161:5772-80. (FC)
  9. 9. Lund FE, Muller-Steffner HM, Yu N, Stout CD, Schuber F, Howard MC. CD38 signaling in B lymphocytes is controlled by its ectodomain but occurs independently of enzymatically generated ADP-ribose or cyclic ADP-ribose. J Immunol. 1999;162:2693-702. (FC)
  10. 10. Reeb-Whitaker CK, Paigen B, Beamer WG, Bronson RT, Churchill GA, Schweitzer IB, et al. The impact of reduced frequency of cage changes on the health of mice housed in ventilated cages. Lab Anim. 2001;35:58-73. (FC)
  11. 11. Musso T, Deaglio S, Franco L, Calosso L, Badolato R, Garbarino G, et al. CD38 expression and functional activities are up-regulated by IFN-γ on human monocytes and monocytic cell lines. J Leukoc Biol. 2001;69:605-12. (FC)
  12. 12. Gliddon DR, Howard CJ. CD26 is expressed on a restricted subpopulation of dendritic cells in vivo. Eur J Immunol. 2002;32:1472-81. (FC)
  13. 13. Bian H, Fournier P, Moormann R, Peeters B, Schirrmacher V. Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus. Cancer Gene Ther. 2005;12:295-303. (FC)
  14. 14. Richman SA, Healan SJ, Weber KS, Donermeyer DL, Dossett ML, Greenberg PD, et al. Development of a novel strategy for engineering high-affinity proteins by yeast display. Protein Eng Des Sel. 2006;19:255-64. (FC)
  15. 15. Janke M, Peeters B, de Leeuw O, Moorman R, Arnold A, Fournier P, et al. Recombinant Newcastle disease virus (NDV) with inserted gene coding for GM-CSF as a new vector for cancer immunogene therapy. Gene Ther. 2007;14:1639-49. (FC)
  16. 16. Apostolidis L, Schirrmacher V, Fournier P. Host mediated anti-tumor effect of oncolytic Newcastle disease virus after locoregional application. Int J Oncol. 2007;31:1009-19. (FC)
  17. 17. Sopp P, Werling D, Baldwin C. Cross-reactivity of mAbs to human CD antigens with cells from cattle. Vet Immunol Immunopathol. 2007;119:106-14. (FC)
  18. 18. Yu KO, Im JS, Illarianov PA, Ndonye RM, Howell AR, Besra GS, et al. Production and characterization of monoclonal antibodies against complexes of the NKT cell ligand α-galactosylceramide bound to mouse CD1d. J Immunol Methods. 2007;323:11-23. (FC)
  19. 19. Janke M, Peeters B, Zhao H, de Leeuw O, Moorman R, Arnold A, et al. Activation of human T cells by a tumor vaccine infected with recombinant Newcastle disease virus producing IL-2. Int J Oncol. 2008;33:823-32. (FC)
  20. 20. Pfirschke C, Schirrmacher V. Cross-infection of tumor cells by contact with T lymphocytes loaded with Newcastle disease virus. Int J Oncol. 2009;34:951-62. (FC)
  21. 21. Fournier P, Aigner M, Schirrmacher V. Transcriptome analysis and cytokine profiling of naive T cells stimulated by a tumor vaccine via CD3 and CD25. Int J Oncol. 2010;37:1439-52. (FC)
  22. 22. Saito E, Fujimoto M, Hasegawa M, Komura K, Hamaguchi Y, Kaburagi Y, et al. CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse. J Clin Invest. 2002;109:1453-62. (ICC)
  23. 23. Pilling D, Buckley CD, Salmon M, Gomer RH. Inhibition of fibrocyte differentiation by serum amyloid P. J Immunol. 2003;171:5537-46. (ICC)
  24. 24. Gan M, Moussaud S, Jiang P, McLean PJ. Extracellular ATP induces intracellular alpha-synuclein accumulation via P2X1 receptor-mediated lysosomal dysfunction. Neurobiol Aging. 2015;36:1209-20. (WB)
  25. 25. Do Y, Rafi-Janajreh AQ, Mckallip RJ, Nagarkatti PS, Nagarkatti M. Combined deficiency in CD44 and Fas leads to exacerbation of lymphoproliferative and autoimmune disease. Int Immunol. 2003;15:1327-40. (Stim)
  26. 26. Liubchenko GA, Appleberry HC, Holers VM, Banda NK, Willis VC, Lyubchenko T. Potentially autoreactive naturally occurring transitional T3 B lymphocytes exhibit a unique signaling profile. J Autoimmun. 2012;38:293-303. (Stim)
See All References

Related Products

Related Products

Related Products
Check items to add to the cart or
  1. ELISA plate was coated with serially diluted Mouse IgG-UNLB (SB Cat. No. 0107-01). Immunoglobulin was detected with Goat Anti-Mouse IgG, Human ads-BIOT (SB Cat. No. 1030-08), Goat Anti-Mouse IgA-BIOT (SB Cat. No. 1040-08), and Goat Anti-Mouse IgM, Human ads-BIOT (SB Cat. No. 1020-08) followed by Streptavidin-HRP (SB Cat No. 7100-05) and quantified.
    Mouse IgG-UNLB
    0107-01
    $132.00
  2. ELISA plate was coated with purified mouse IgG, IgM, and IgA. Immunoglobulins were detected with serially diluted Goat Anti-Mouse IgG, Human ads-HRP (SB Cat. No. 1030-05).
    Goat Anti-Mouse IgG, Human ads-HRP
    1030-05
    $121.00
  3. Human pancreatic carcinoma cell line MIA PaCa-2 was blocked with 10% Normal Goat Serum (SB Cat. No. 0060-01) and stained with Mouse Anti-Cytokeratin 18-UNLB (SB Cat. No. 10085-01; right) followed by Goat Anti-Mouse IgG(H+L), Human ads-AF555 (SB Cat. No. 1031-32) and DAPI.
    Normal Goat Serum
    0060-01
    $44.00
  4. Frozen newborn mouse cartilage section was stained with Goat Anti-Type V Collagen-UNLB (SB Cat. No. 1350-01) followed by Donkey Anti-Goat IgG(H+L), Multi-Species SP ads-AF555 (SB Cat. No. 6425-32) and DAPI.
    Donkey Anti-Goat IgG(H+L), Multi-Species SP ads-AF555
    6425-32
    $259.00
  5. ELISA plate was coated with purified mouse IgG<sub>1</sub>, IgG<sub>2a</sub>, IgG<sub>2b</sub>, IgG<sub>3</sub>, IgM, and IgA. Immunoglobulins were detected with serially diluted Goat Anti-Mouse IgG<sub>2a</sub>, Human ads-HRP (SB Cat. No. 1080-05).
    Goat Anti-Mouse IgG2a, Human ads-HRP
    1080-05
    $146.00
  6. Paraffin embedded human gastric cancer tissue was stained with Goat IgG-UNLB isotype control (SB Cat. No. 0109-01; left) and Goat Anti-Type VI Collagen-UNLB (SB Cat. No. 1360-01; right) followed by Swine Anti-Goat IgG(H+L), Human/Rat/Mouse SP ads-BIOT (SB Cat. No. 6300-08), Streptavidin-HRP (SB Cat. No. 7100-05), DAB, and hematoxylin.
    Swine Anti-Goat IgG(H+L), Human/Rat/Mouse SP ads-BIOT
    6300-08
    $105.00
  7. ELISA plate was coated with serially diluted Goat F(ab')<sub>2</sub> IgG-UNLB (SB Cat. No. 0110-01). Immunoglobulin was detected with Rabbit Anti-Goat IgG Fab-BIOT (SB Cat. No. 6022-08) and Mouse Anti-Goat IgG Fc-BIOT (SB Cat. No. 6157-08) followed by Streptavidin-HRP (SB Cat No. 7100-05) and quantified.
    Goat F(ab')2 IgG-UNLB
    0110-01
    $191.00
  8. Donkey Anti-Goat IgG(H+L), Mouse/Rat SP ads-AF647
    Donkey Anti-Goat IgG(H+L), Mouse/Rat SP ads-AF647
    6420-31
    $225.00
  9. ELISA plate was coated with purified mouse IgA, IgG, and IgM. Immunoglobulins were detected with serially diluted Goat Anti-Mouse IgA-HRP (SB Cat. No. 1040-05).
    Goat Anti-Mouse IgA-HRP
    1040-05
    $150.00